• The prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030
    Roots Analysis has done a detailed study on Prefilled Syringe Fill / Finish Services Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

    To order this 260+ page report, which features 60+ figures and 110+ tables, please visit Prefilled Syringe Fill / Finish Services Market, 2020-2030

    Key Market Insights
     Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.
     The market landscape features the presence of well- established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.
     In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.
     Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.
     As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.
     The demand for fill / finish services for prefilled syringes is likely to steadily increase in the coming years; we believe stakeholders may have to expand their respective capacities to ensure a consistent supply.
     An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.
     Caste Study: Around 70 prefilled syringes are being manufactured by large companies, most of which claim to be capable of fabricating syringe barrels from both glass and plastic materials.
     We expect drug developers to continue to outsource their fill / finish operations in the short to mid term, resulting in an annualized growth at the rate of over 8% within the contract services market.
     In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.

    For more information, please visit https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

    Table of Contents

    1. PREFACE
    1.1. Chapter Overview
    1.2. Scope of the Report
    1.3. Research Methodology
    1.4. Chapter Outlines

    2. EXECUTIVE SUMMARY

    3. INTRODUCTION
    3.1. Chapter Overview
    3.2. Introduction to Prefilled Syringes
    3.2.1. Classification of Prefilled Syringes
    3.2.2. Manufacturing of Prefilled Syringes
    3.2.3. Advantages of Prefilled Syringes
    3.2.3.1. Benefits to Healthcare Professionals and End Users
    3.2.3.2. Benefits to Manufacturers

    3.3. Fill / Finish Processing of Prefilled Syringes
    3.3.1. Steps Involved in Fill / Finish Process
    3.3.2. Methods of Filling and Stoppering of Prefilled Syringes
    3.3.3. Prefilled Syringe Filling Technologies

    3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
    3.5. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
    3.6. Advantages of Outsourcing Fill / Finish Services
    3.7. Risks Associated with Outsourcing of Fill / Finish Operations
    3.8. Key Considerations While Selecting a Fill / Finish Service Provider

    4. MARKET LANDSCAPE
    4.1. Chapter Overview
    4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
    4.2.1. Analysis by Year of Establishment
    4.2.2. Analysis by Company Size
    4.2.3. Analysis by Scale of Operation
    4.2.4. Analysis by Location of Headquarters
    4.2.5. Analysis by Location of Prefilled Syringe Fill / Finish Facilities
    4.2.6. Analysis by Type of Drug Molecule
    4.2.7. Analysis by Syringe Barrel Material
    4.2.8. Analysis by Syringe Fill Volume
    4.2.9. Analysis by Additional Services Offered
    4.2.10. Heat Map: Analysis by Company Size and Location of Headquarters
    4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
    4.2.12. Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities
    4.2.13. Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule

    5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
    5.1. Chapter Overview
    5.2. Ajinomoto Bio-Pharma Services
    5.2.1. Company Overview
    5.2.2. Recent Developments and Future Outlook

    5.3. AMRI
    5.3.1. Company Overview
    5.3.2. Recent Developments and Future Outlook

    5.4. BioPharma Solutions
    5.4.1. Company Overview
    5.4.2. Recent Developments and Future Outlook

    5.5. Emergent BioSolutions
    5.5.1. Company Overview
    5.5.2. Recent Developments and Future Outlook

    5.6. Patheon (a Thermo Fisher Scientific Company)
    5.6.1. Company Overview
    5.6.2. Recent Developments and Future Outlook



    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    Prefilled Syringe Fill / Finish Services | Industry Analysis | Market Size | 2030
    Market research report on prefilled syringe (PFS) fill / finish services; with a focus on current market landscape and future growth opportunities
    WWW.ROOTSANALYSIS.COM
    0 0 Commenti 0 Shares
  • The market is divided, including the presence of both industry and non-industry players that are associated , claims Roots Analysis

    With the growing prominence of peptide-based therapeutics and personalized medicine, there is an increased demand for rapid, highly sensitive, and accurate quantification methods to analyze clinical specimens. As a result, proteome profiling has become an indispensable part of modern drug discovery and development process, as well as disease diagnosis.

    To order this 290+ page report, which features 50+ figures and 100+ tables, please visit https://www.rootsanalysis.com/reports/proteome-profiling-services.html

    The USD 16 billion (by 2030) financial opportunity within the proteome profiling services market has been analyzed across the following segments:
     Application Area
     Drug Discovery
     Disease Diagnosis
     Others

     Type of Sponsor(s)
     Contract Research Organizations
     Pharmaceutical Companies
     Research and Academic Institutes

     Key Geographical Regions
     North America
     Europe
     Asia Pacific
     Rest of the World

    The Proteome Profiling Services Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
     Biognosys
     BGI
     Bioproximity
     Cell Signaling Technology
     Creative Biolabs
     Creative Proteomics
     Cytomics
     i-DNA Biotechnology
     NMI TT Pharmaservices
     Poochon Scientific
     Proteomics International
     Proteome Factory
     Sciomics
     tebu-bio
     VProteomics


    Table of Contents

    1. PREFACE

    2. EXECUTIVE SUMMARY

    3. INTRODUCTION

    4. MARKET LANDSCAPE

    5. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN NORTH AMERICA

    6. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN EUROPE

    7. COMPANY PROFILES: PROTEOME PROFILING SERVICE PROVIDERS IN ASIA PACIFIC AND REST OF THE WORLD

    8. COMPANY COMPETITIVENESS ANALYSIS

    9. PARTNERSHIPS AND COLLABORATIONS

    10. SWOT ANALYSIS

    11. MARKET FORECAST AND OPPORTUNITY ANALYSIS

    12. IMPACT OF THE COVID-19 PANDEMIC ON PROTEOME PROFILING SERVICES MARKET

    13. CONCLUDING REMARKS

    14. EXECUTIVE INSIGHTS

    15. APPENDIX 1: TABULATED DATA

    16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

    To purchase a copy, please visit https://www.rootsanalysis.com/reports/proteome-profiling-services.html or email sales@rootsanalysis.com

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    Proteome Profiling Services | Industry Analysis | Market Size | 2030
    Market research report on proteome profiling services with a focus on current market landscape and future growth opportunities
    WWW.ROOTSANALYSIS.COM
    0 0 Commenti 0 Shares
  • Worldwide Psychedelic therapeutics market is projected to develop at an annualized pace of ~15%, till 2030

    Roots Analysis has done a detailed study on “Global Psychedelic Therapeutics Market, 2020-2030”, covering key aspects of the industry and identifying potential future growth opportunities


    To order this 250+ page report, which features 120+ figures and 135+ tables, please visit Global Psychedelic Therapeutics Market, 2020-2030

    Key Market Insights
     Nearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin
     The pipeline features product candidates based on a variety of psychedelic drug classes, which are being investigated for a wide range of target disease indications, and having different routes of administration
     From a global perspective, this industry is anticipated to evolve significantly over the next few years as federal / regional regulators in different nations are gradually convinced of the clinical significance of this product class
     Several organizations, having realized the untapped opportunity within this emerging segment of psychedelic therapeutics, have awarded grants of over USD 275 million across 500+ instances between 2015-2020
     Several trials evaluating various psychedelic compounds against a wide range of therapeutic indication have been registered in the recent past
     The growing interest is also reflected in the partnership activity since 2017; a number of different types of deals involving various drug classes have been established across multiple geographies
     Presently, North American companies are actively consolidating their indigenous presence through strategic acquisitions; key value drivers behind such deals include both portfolio and geographical expansion
     A number of eminent scientists from renowned universities have emerged as key opinion leaders in this domain, owing to their active involvement in clinical development efforts related to interventions based on psychedelics
     Future market size, based on revenue reported from the sales of marketed and late stage psychedelic-based therapies, is anticipated to be distributed across different therapeutic areas and key geographical regions

    For more information, please visit https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html


    Table of Contents

    1. PREFACE
    1.1. Scope of the Report
    1.2. Research Methodology
    1.3. Chapter Outlines

    2. EXECUTIVE SUMMARY

    3. INTRODUCTION
    3.1. Chapter Overview
    3.2. History of Psychedelic Substance
    3.3. Potential Therapeutic Application of Psychedelic Substance
    3.4. Regulation, Toxicity Concerns, Procurement-Related Challenges and Perceptions Regarding Medical Use
    3.5. Future Opportunity

    4. MARKET LANDSCAPE: PSYCHEDELIC THERAPEUTICS
    4.1. Chapter Overview
    4.2. Psychedelic Therapeutics: Marketed and Development Pipeline
    4.2.1. Analysis by Phase of Development
    4.2.2. Analysis by Type of Psychedelic Substance
    4.2.3. Analysis by Origin of Psychedelic Substance
    4.2.4. Analysis by Target Therapeutic Area
    4.2.5. Analysis by Type of Therapy
    4.2.6. Analysis by Route of Administration
    4.2.7. Analysis by Dosing Frequency

    4.3. Psychedelic Therapeutics: List of Developers
    4.3.1. Analysis by Year of Establishment
    4.3.2. Analysis by Company Size
    4. 3.3. Analysis by Location of Headquarters
    4.4. Grid Analysis: Distribution by Phase of Development, Origin of Psychedelic Substance and Location of Headquarters

    5. COMPANY PROFILES
    5.1. Chapter Overview

    5.2. Celon Pharma
    5.2.1. Company Overview
    5.2.2. Financial Information
    5.2.3. Psychedelic Therapeutics Portfolio
    5.2.3.1. Esketamine DPI
    5.2.4. Recent Developments and Future Outlook

    5.3. iX Biopharma
    5.3.1. Company Overview
    5.3.2. Financial Information
    5.3.3. Psychedelic Therapeutics Portfolio
    5.3.3.1. Wafermine™
    5.3.3.2. Unnamed (Ketamine)
    5.3.4. Recent Developments and Future Outlook

    5.4. MAPS Public Benefit
    5.4.1. Company Overview
    5.4.2. Financial Information
    5.4.3. Psychedelic Therapeutics Portfolio
    5.4.3.1. Unnamed (MDMA)
    5.4.3.2. Unnamed (Ibogaine Hydrochloride)
    5.4.3.3. Unnamed (LSD)
    5.4.3.4. Unnamed (Ayahuasca)
    5.4.4. Recent Developments and Future Outlook

    5.5. MindMed
    5.5.1. Company Overview
    5.5.2. Psychedelic Therapeutics Portfolio
    5.5.2.1. Unnamed (LSD)
    5.5.2.2. Unnamed (MDMA)
    5.5.2.3. 18-MC
    5.5.2.4. Unnamed (DMT)
    5.5.2.5. Unnamed (LSD, MDMA)
    5.5.3. Recent Developments and Future Outlook

    5.6. Janssen Pharmaceuticals
    5.6.1. Company Overview
    5.6.2. Financial Information
    5.6.3. Psychedelic Therapeutics Portfolio
    5.6.3.1. SPRAVATO®
    5.6.4. Recent Developments and Future Outlook

    5.7. Jazz Pharmaceutical
    5.7.1. Company Overview
    5.7.2. Financial Information
    5.7.3. Psychedelic Therapeutics Portfolio
    5.7.3.1. XYREM®
    5.7.3.2. JZP-258
    5.7.3.3. JZP-324
    5.7.4. Recent Developments and Future Outlook

    6. CLINICAL TRIAL ANALYSIS
    6.1. Chapter Overview
    6.2. Scope and Methodology
    6.3. Psychedelic Therapeutics: Clinical Trial Analysis
    6.3.1. Analysis by Trial Registration Year
    6.3.2. Analysis by Trial Phase
    6.3.3. Analysis by Trial Recruitment Status
    6.3.4. Analysis by Trial Registration Year and Number of Patients Enrolled
    6.3.5. Analysis by Study Design
    6.3.6. Leading Trial Sponsors: Analysis by Number of Registered Trials
    6.3.7. Leading Players: Analysis by Number of Registered Trials
    6.3.8. Analysis by Trial Focus
    6.3.9. Analysis by Target Therapeutic Area
    6.3.10. Popular Psychedelic Substance: Analysis by Number of Registered Trials
    6.3.11. Geographical Analysis by Number of Registered Trials
    6.3.12. Geographical Analysis by Number of Patients Enrolled


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    1234
    1234
    WWW.ROOTSANALYSIS.COM
    0 0 Commenti 0 Shares
  • The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis
    A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Biologics Fill / Finish Services Market, 2019-2030.”

    The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry. The study features in-depth analysis, highlighting the capabilities of a diverse set of companies that claim to specialize in fill / finish operations. Amongst other elements, the report includes:
     A detailed review of the overall landscape of contract fill / finish services market for biopharmaceuticals.
     A region-wise, company competitiveness analysis, highlighting prominent fill / finish service providers across various packaging types.
     Elaborate profiles of key players across key geographies (North America, Europe and Asia-Pacific).
     An analysis of the recent collaborations (signed since 2013) focused on the contract fill / finish services for biologics.
     A detailed analysis of the expansions undertaken (since 2013) by various service providers for augmenting their respective fill / finish service portfolios.
     An estimate of the global contract fill / finish capacity, by taking into consideration the capacities of various fill / finish service providers.
     An informed estimate of the annual demand for fill / finish of biologics, taking into account the top 20 biologics.
     An analysis to identify the key performance indicators for service providers active in the domain.
     A case study to highlight the benefits of using robotic / automated equipment for aseptic fill / finish processes.
     A case study to highlight the role of ready-to-use packaging containers in aseptic fill / finish operations.
     A discussion on the potential growth areas and recent trends impacting the outsourcing potential for biopharmaceuticals.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Types of Primary Packaging Containers
     Ampoules
     Cartridges
     Syringes
     Vials
     Types of Biologics
     Peptides / proteins
     Antibodies
     Vaccines
     Cell therapies
     Gene therapies
     Viral products
     Oligonucleotides
     Others

     Company Size
     Small-sized
     Mid-sized
     Large / very large

     Scale of Operation
     Preclinical
     Clinical
     Commercial

     Key Therapeutic Areas
     Cancer
     Infectious diseases
     Autoimmune diseases
     Cardiovascular diseases
     Other indications

     Key Geographical Regions
     North America (US, Canada)
     Europe (UK, France, Germany, Italy, Spain and rest of the Europe)
     Asia-Pacific (Japan, China, South Korea, India and Australia)

    The report features inputs from a number of eminent industry stakeholders, according to whom, “Currently, majority of biologics are being filled in vials, however, the scenario is likely to change in the future due to the growing demand and preference for self-administration devices.” The report features detailed transcripts of discussions held with the following experts:
     Ales Sima, Business Development Manager, oncomed manufacturing
     Gregor Kawaletz, Chief Commercial Officer, IDT Biologika
     Jos Vergeest, International Business Developer, HALIX
     Purushottam Singnurkar, Research Director and Head of Formulation Development, Syngene International

    Key companies covered in the report
     Advanced BioScience Laboratories (ABL)
     Albany Molecular Research (AMRI)
     Biocon
     BioPharma Solutions
     BioReliance
     Boehringer Ingelheim BioXcellence
     ChemPartner
     Emergent BioSolutions
     IDT Biologika
     Lonza
     LuinaBio
     Mycenax Biotech
     Patheon
     Recipharm
     Vetter Pharma
     WuXi Biologics

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

    Other Recent Offerings
    1. Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030
    2. Medical Device Contract Manufacturing Market, 2019-2030
    3. Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures
    4. Biopharma Contract Manufacturing Market (3rd Edition), 2019 - 2030
    5. Patient Recruitment and Retention Services Market, 2019-2030


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    0 0 Commenti 0 Shares
  • AR / VR based digital marketing service providers in healthcare sector is projected claims, Roots Analysis
    Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies

    Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings.

    Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers in the foreseen future. Owing to the rising interest of big pharma players in this domain, we expect an escalated industry-wide adoption of such technologies.

    To order this 180+ page report, which features 45+ figures and 70+ tables, please visit AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

    Key Market Insights

    More than 125 companies claim to offer different AR / VR based digital marketing services to the healthcare and pharma industry.
    The majority of players engaged in providing AR / VR based digital marketing services to the healthcare and pharmaceutical industry are small-sized companies (63%), followed by mid-sized (32%) and large players (5%). In addition, majority (38%) of the players were established during the period 2011-2015.

    Several big pharma players have taken significant strides in in the field of AR / VR
    These instances are either by collaborating with digital marketing service providers or through development of in-house capabilities. Majority (18%) of the instances were recorded in the year 2018.

    More than 350 industry players have been identified as likely partners for AR / VR based digital marketing service providers
    The potential strategic partners have been identified by evaluating more than 4,500 industry sponsored clinical trials (including phase I / II, phase II and phase II / III trials), and have been analyzed based on our proprietary scoring criteria.

    Currently, a significant proportion (57%) of service revenues is generated from AR based digital marketing projects
    In 2020, VR based projects are anticipated to contribute to 42% of the overall market share. It is worth mentioning that, in the foreseen future, service revenues generated through MR based technologies are anticipated to grow at a CAGR of 5% till 2030.

    To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

    Key Questions Answered
     Who are the leading players offering AR / VR based digital marketing services?
     Which immersive technology, AR or VR, is likely to witness greater adoption in the immediate future?
     How have big pharma players used AR / VR to create interactive and immersive experiences for their consumers?
     Which companies are potential strategic partners for AR / VR based digital marketing service providers?
     What are the factors that are likely to influence the evolution of this market?
     How is the current and future opportunity likely to be distributed across key market segments?

    The USD 3.04 billion (by 2030) financial opportunity within the AR / VR based healthcare digital marketing service providers market has been analyzed across the following segments:
     Type of Technology
     AR Based Services
     MR Based Services
     VR Based Services

     Type of product
     Hardware
     Software

     End-User
     Large Companies
     Small and Mid-sized Companies

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Rest of the World

    The report features inputs from eminent industry stakeholders, according to whom, a significant increase in adoption of AR / VR based digital marketing services is anticipated in pharmaceutical industry, in the foreseen future. The report includes detailed transcripts of the discussions held with the following experts:
     Dhananjay Arora (CEO, Kwebmaker)
     Pritam Sahu (Director, Unanimity Information & Technology)

    The research includes detailed profiles of key players engaged in this domain; each profile features an overview of the company, recent developments and an informed future outlook.
     ARWorks
     CG Life
     CubeZoo
     Impact XM
     INVIVO Communications
     Mirum
     Pixacore
     Random42
     Quast Media
     Tipping Point Media
     vStream

    For additional details, please visit
    https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html

    You may also be interested in the following titles:
    1. Global Collaborative Robots (Cobots) Market, 2020-2030
    2. Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030
    3. Digital Twin Market: Global Opportunity and Trend Analysis, 2020-2035

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    AR / VR based Healthcare Digital Marketing Service Providers Market | Market Size | Industry Analysis | 2030
    Market research report on AR / VR based healthcare digital marketing service providers with a focus on current market landscape and future opportunities
    WWW.ROOTSANALYSIS.COM
    0 0 Commenti 0 Shares
  • Prefilled syringe fill / finish services market, predicts Roots Analysis

    The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe Fill / Finish Services Market, 2020-2030.”

    The report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes. The study features an in-depth analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:
     A detailed review of the overall landscape of companies offering contract fill / finish services for prefilled syringes
     Tabulated profiles of key players (shortlisted based on a proprietary criterion) across key geographies, such as North America, Europe and Asia-Pacific.
     An analysis of the recent developments (since 2015) pertaining to contract fill / finish services, based on various parameters
     An estimate of the global, contract fill / finish capacity of prefilled syringes, by taking into consideration the capacities of various fill / finish service providers (as available on respective company websites), collected via secondary and primary research.
     An informed estimate of the annual demand for fill / finish of prefilled syringes (in number of units), taking into account the marketed drugs available in prefilled syringes and other relevant parameters, such as target patient population, dosing frequency and dose strength.
     A detailed demand and supply assessment of geographies in this domain.
     An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe fill / finish service providers.
     A discussion on the potential growth areas in this domain.
     A review of the landscape of prefilled syringe manufacturers.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Scale of Operation
     Preclinical / Clinical
     Commercial
     Type of Drug Molecule
     Biologic
     Small Molecule
     Target Therapeutic Area
     Blood Disorders
     Infectious Diseases
     Metabolic Disorders
     Oncological Disorders
     Neurological Disorders
     Autoimmune Disorders
     Others
     Syringe Barrel Material
     Glass
     Plastic
     Number of Barrel Chambers
     Single Chamber
     Dual Chamber
     Key Geographical Region
     North America
     Europe
     Latin America
     Asia-Pacific
     Middle East and Africa

    Key companies covered in the report
     Ajinomoto Bio-Pharma Services
     AMRI
     BioPharma Solutions
     Emergent BioSolutions
     Patheon
     Consort Medical
     EVER Pharma
     GlaxoSmithKline
     IDT Biologika
     Rentschler Biopharma
     Siegfried
     Vetter Pharma
     Biocon
     Intas Pharmaceuticals
     Kemwell Biopharma
     Square Pharmaceuticals

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/view_document/prefilled-syringe-fill-finish-services/301.html

    Other Recent Offerings
    1. Prefilled Syringes Market (5th Edition), 2020-2030
    2. Biologics Fill / Finish Services Market, 2019-2030


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    Prefilled Syringe Fill / Finish Services | Industry Analysis | Market Size | 2030
    Market research report on prefilled syringe (PFS) fill / finish services; with a focus on current market landscape and future growth opportunities
    WWW.ROOTSANALYSIS.COM
    0 0 Commenti 0 Shares
  • The proteome profiling services market is projected to be worth USD 16 billion by 2030.

    Proteome profiling is a technically complex and financially demanding field of research, as a result both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Proteome Profiling Services Market, 2020-2030.”

    The report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers. The study also features a detailed analysis of the key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

     A detailed review of the overall landscape of companies offering proteome profiling services, along with information on type of service provider, year of establishment, company size, location of headquarters, service(s) offered for pre-proteome profiling, service(s) offered for proteome profiling, other service(s) offered, type of product profiled and type of sample(s) used.
     Detailed profiles of prominent proteome profiling players (shortlisted on the basis of the number of pipeline services).
     An analysis of the partnerships that have been established in this domain, in the recent past.
     A competitiveness analysis of proteome profiling services, featuring insightful pictorial summaries and representations.
     An elaborate discussion on various factors contributing to the high price of proteome profiling.
     A discussion on affiliated trends, key drivers and challenges which are likely to impact the industry’s evolution, under a comprehensive SWOT framework.
     A detailed review of the impact of the COVID-19 pandemic on the overall proteome profiling services market.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
     Application Area
     Drug Discovery
     Disease Diagnosis
     Others

     Type of Sponsor(s)
     Contract Research Organizations
     Pharmaceutical Companies
     Research and Academic Institutes

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific and the Rest of the World

    Key companies covered in the report
     Biognosys
     BGI
     Bioproximity
     Cell Signaling Technology
     Creative Biolabs
     Creative Proteomics
     Cytomics
     i-DNA Biotechnology
     NMI TT Pharmaservices
     Poochon Scientific
     Proteomics International
     Proteome Factory
     Sciomics
     tebu-bio
     VProteomics

    For more information please click on the following link:
    https://www.rootsanalysis.com/reports/proteome-profiling-services.html

    Other Recent Offerings
    1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030
    2. Peptide Therapeutics: Contract API Manufacturing Market, 2020 - 2030
    3. Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PROTACs, Protein Homeostatic Modulators, SARDs, SERDs, SNIPERs, and Specific BET and DUB Inhibitors), 2020-2030


    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis

    Proteome Profiling Services | Industry Analysis | Market Size | 2030
    Market research report on proteome profiling services with a focus on current market landscape and future growth opportunities
    WWW.ROOTSANALYSIS.COM
    0 0 Commenti 0 Shares
  • Global Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030.
    A growing body of evidence suggests that using psychedelics, such as psilocybin and LSD, in combination with psychotherapy, can treat the symptoms of several mental health conditions, including depression and substance use disorders

    Roots Analysis has announced the addition of “Global Psychedelic Therapeutics Market, 2020-2030” report to its list of offerings.

    The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
     A detailed assessment of the current market landscape of drug developers engaged in the development of psychedelic therapeutics.
     Tabulated profiles of prominent psychedelic therapeutics developers. shortlisted on the basis of the number of pipeline products).
     Detailed profiles of developers of next generation immune checkpoint modulators (shortlisted on the basis having two or more psychedelics-based therapies in phase II clinical studies and above).
     An insightful analysis of clinical trial sites where the studies have been / are being conducted for evaluation of various psychedelic therapeutics.
     A list of key opinion leaders (KOLs) within this domain, and detailed 2×2 matrices to assess the relative experience of key individuals who were shortlisted based on their contributions (in terms of involvement in various clinical studies) to this field.
     A detailed analysis of nearly 545 grants that have been awarded to research institutes engaged in psychedelic therapeutics projects, in the period between 2015 and 2020 (till May).
     An analysis of the partnerships that have been established in the recent past (2017-2020 till May),
     A detailed analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2017-2020.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
     Target Disease Indication
     Anxiety and Depression
     Trauma
     Pain Disorder
     Sleep related Disorder
     Origin of Psychedelic Substance
     Natural
     Synthetic
     Type of Psychedelic Substance
     Gamma-hydroxybutyrate
     Ketamine
     MDMA
     Psilocybin
     Route of Administration
     Oral
     Intranasal
     Sublingual
     Key Geographies
     North America
     Europe
     Asia-Pacific
    Transcripts of interviews held with the following senior level representatives of stakeholder companies
     Andrew Chadeayne (Founder & Chief Executive Officer, CaaMTech)
     Janakan Krishnarajah (Chief Operating Officer and Chief Medical Officer, iX Biopharma)
     Alexander Speiser (Chief Operating Officer, Orthogonal Thinker)
     Tracy Cheung, (Chief Communications Officer, COMPASS Pathways)
    Key companies covered in the report
     Celon Pharma
     iX Biopharma
     MAPS Public Benefit
     MindMed
     Janssen Pharmaceuticals
     Jazz Pharmaceutical

    For additional details, please visit
    https://www.rootsanalysis.com/reports/global-psychedelic-therapeutics-market.html or email sales@rootsanalysis.com

    You may also be interested in the following titles:
    1. Endocannabinoid System Targeted Therapeutics Market, 2020-2030
    2. Depressive Disorders (Major Depression, Bipolar Disorder, Postpartum Depression, Treatment-Resistant Depression and Others): Pipeline Review, Developer Landscape and Competitive Insights, 2019
    3. Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights
    4. Neoantigen Targeted Therapies Market, 2019-2030
    5. Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics

    About Roots Analysis
    Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

    Contact Information
    Roots Analysis Private Limited
    Gaurav Chaudhary
    +1 (415) 800 3415
    ben.johnson@rootsanalysis.com
    Facebook - https://www.facebook.com/RootsAnalysis
    LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
    Twitter - https://twitter.com/RootsAnalysis
    1234
    1234
    WWW.ROOTSANALYSIS.COM
    0 0 Commenti 0 Shares
  • With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
    With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic.   Roots Analysis is pleased to...
    0 0 Commenti 0 Shares
  • The CAR-T therapies market is characterized by a healthy pipeline of promising therapies
    Given the success of approved CAR-T cell therapies, such as KYMRIAH®, YESCARTA®, TECARTUS® and BREYANZI®, this upcoming class of biologics are anticipated to carve out a significant share of the multi-billion dollar cancer immunotherapy market   Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL,...
    0 0 Commenti 0 Shares
Altre storie